Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ruby Freeman

Showing results (1-10 of 3) with videos related to

Pageof 1
Sort By:
Molecular Therapy. Oncology|September 30, 2024
Muc16CD is a novel CAR T cell target antigen for the treatment of pancreatic cancerHeather K Lin, Dejah A Blake, Tongrui Liu, et al.
Advanced Healthcare Materials|January 21, 2024
Engineering Improved CAR T Cell Products with A Multi-Cytokine Particle Platform for Hematologic and Solid TumorsHeather K Lin, Biaggio Uricoli, Ruby Freeman, et al.
Journal for Immunotherapy of Cancer|May 21, 2024
Developing a membrane-proximal CD33-targeting CAR T cellRuby Freeman, Sanam Shahid, Abdul G Khan, et al.
Pageof 1

Showing results (1-10 of 3) with videos related to

Sort By:
Pageof 1
Molecular Therapy. Oncology|September 30, 2024
Muc16CD is a novel CAR T cell target antigen for the treatment of pancreatic cancerHeather K Lin, Dejah A Blake, Tongrui Liu, et al.
Advanced Healthcare Materials|January 21, 2024
Engineering Improved CAR T Cell Products with A Multi-Cytokine Particle Platform for Hematologic and Solid TumorsHeather K Lin, Biaggio Uricoli, Ruby Freeman, et al.
Journal for Immunotherapy of Cancer|May 21, 2024
Developing a membrane-proximal CD33-targeting CAR T cellRuby Freeman, Sanam Shahid, Abdul G Khan, et al.
Pageof 1